Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Daily sumatriptan for detoxification from rebound.

P Drucker1, S Tepper

  • 1University of Washington School of Medicine, Seattle, WA 98122, USA.

Headache
|December 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differences in homeostatic model assessment (HOMA) values and insulin levels after vitamin D supplementation in healthy men: a double-blind randomized controlled trial.

Diabetes, obesity & metabolism·2016
Same author

Identifying the threshold for vitamin D insufficiency in relation to cardiometabolic markers.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2014
Same author

Preventive treatment in migraine and the new US guidelines.

Neuropsychiatric disease and treatment·2013
Same author

Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.

Epidemiology and infection·2005
Same author

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.

Neurology·2004
Same author

A six-item short-form survey for measuring headache impact: the HIT-6.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2003
Same journal

Safety and tolerability of transnasal evaporative cooling for the acute treatment of migraine in an at-home setting: A randomized, double-blind, sham-controlled, decentralized clinical trial.

Headache·2026
Same journal

Biochemical profiling and symptomatology of androgen deficiency in males with cluster headache: A prospective case-control study.

Headache·2026
Same journal

Thiamine deficiency in patients with chronic migraine: A case-control study.

Headache·2026
Same journal

Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.

Headache·2026
Same journal

Potential role of tirzepatide, a dual GLP-1 and GIP receptor agonist, for preventive treatment of migraine: A case series.

Headache·2026
Same journal

Adverse childhood experiences, migraine, and adverse pregnancy outcomes among teenage mothers.

Headache·2026
See all related articles

Oral sumatriptan can help patients with chronic daily headache due to medication overuse. This approach successfully detoxified participants, restoring their episodic migraine pattern and reducing headache frequency.

Area of Science:

  • Neurology
  • Clinical Pharmacology

Background:

  • Medication overuse can transform episodic migraine into chronic daily headache, a condition known as rebound headache.
  • Current detoxification protocols often require inpatient treatment, such as intravenous dihydroergotamine.

Purpose of the Study:

  • To investigate the efficacy of oral sumatriptan as an outpatient detoxification bridge for patients with chronic daily headache caused by medication overuse.
  • To assess the potential for restoring the episodic migraine pattern in these patients.

Main Methods:

  • Patients meeting International Headache Society (IHS) criteria for episodic migraine with >15 headache days/month were enrolled.
  • Participants were instructed to take 25 mg oral sumatriptan three times daily for 10 days or until headache-free for 24 hours.

Related Experiment Videos

Main Results:

  • Of 26 patients initiating the protocol, 58% reverted to an episodic migraine pattern within 1 month.
  • At 6 months, 69% of patients were no longer experiencing chronic daily headache.

Conclusions:

  • Oral sumatriptan can be an effective outpatient strategy for detoxifying patients with medication-overuse-induced chronic daily headache.
  • This method facilitates the transition from chronic daily headache to an episodic migraine pattern during the withdrawal period.